Coalition for Access to NCD Medicines & Products

The Coalition for Access to NCD Medicines & Products is a multisectoral alliance that seeks to address gaps in access to affordable medicines and products for noncommunicable diseases.

coalition4ncds.org

Overview

Non-communicable diseases (NCDs) are the leading cause of early deaths globally, responsible for three in every four premature deaths and costing $2 trillion each year in lost productivity and health care costs, despite being treatable and preventable.

Launched in 2017, the Coalition for Access to NCD Medicines & Products (Coalition) is a multisectoral alliance of governments, private sector entities, nongovernmental organizations, academic institutions, civil society, and foundations that seeks to address gaps in access to affordable medicines and products for NCDs.

Its vision is for all people living with NCDs in resource-limited settings to have access to affordable basic technologies and medicines, including generics, required for diagnosis and treatment in both public and private service delivery points, ultimately reducing the impact of NCDs, such as diabetes, hypertension, and cardiovascular disease as well as mental health.

Approach

Through its cross-sectoral partnership model, the Coalition enables a greater understanding of NCDs and drivers of supply, financing, and service gaps.

Through technical support, advocacy, and resource mobilization, the Coalition partners with ministries of health to address barriers and identify opportunities to strengthen supply security for people living with NCDs. This includes work to:

Facilitate further testing of promising people-centered innovations that address persistent barriers
Amplify joint advocacy
Generate evidence to drive policy change and sustained and systemic scale of proven interventions that increase access to NCD medicines and health products in low- and middle-income countries.

The Coalition also focuses on advancing high-impact implementation programs that strengthen supply chains—including forecasting, procurement, and supply chain management—and rational use of essential products, enhance health system capacity, and increase financing for NCDs.

Partnering with countries to close NCD gaps

The Coalition partners closely with countries to advance national priorities for NCDs. In 2025, this included ongoing engagement with ministries of health in more than five countries to shape bold commitments announced during the United Nations High-Level Meeting on NCDs and Mental Health (NCD HLM), identifying concrete steps they plan to take to close persistent NCD financing and access gaps and contribute to efforts to achieve global 2030 NCD targets.

Generating evidence on innovative supply, care, and financing solutions

Through its Demonstration Project taskforce, the Coalition has worked across its membership, countries, and other partners to mobilize funding and offer technical support to test and scale promising approaches that strengthen NCD care and systems. Recent initiatives include co-developing and standardizing a user-friendly NCD commodity forecasting and quantification tool (NCD4Cast), testing and further refining the tool across three countries. The Coalition has also co-designed and evaluated Diabetes CarePak in five countries – a last mile “co-packaged” self-care solution that equips people living with diabetes with information and supplies for safe insulin administration, with results shared at major global NCD convenings in 2025.

Elevating NCD priorities through advocacy

The Coalition woks across global and regional platforms to raise visibility of critical challenges affecting supply security and access to NCD medicines and products and call for resourcing and action to address these challenges. In the lead up to NCD HLM, the Coalition engaged membership to share reflections on the Zero Draft of the Political Declaration, highlighted financing and partnership priorities during the Multistakeholder Hearing, and released a white paper outlining practical strategies to better invest in NCDs.

How IFPMA supports the Coalition

IFPMA is a founding member of the Coalition and serves as the private sector representative on the Coalition’s Steering Committee.

Alongside our member companies that belong to the Coalition, we bring unique industry-specific perspectives to discussions on access to NCD products, such as the lessons learned from our involvement in different initiatives that aim to expand access and affordability of our NCD treatments.

In addition to IFPMA, the Coalition has over 20 members and benefits from a technical advisory committee of global leaders in NCD testing, care, and systems who advise the Coalition on strategy setting, operations, and linkages to other global initiatives to jointly amplify efforts.

Investing in NCDs

The NCD Coalition calls for prioritized financing for health and NCDs in national budgets, efficient NCD supply chains, and strengthened transparency in NCD financing flows.

Learn more